Schizo Flashcards

1
Q

What is the DSM-5 Criteria for Schizophrenia?

A

1) ≥ 2 symptoms, each persisting for a significant portion of at least 1 month period
* Positive Symptoms: (symptoms that normal person without schizophrenia also has, but just amplified in schizo patients)
o (1) Delusions
o (2) Hallucinations
o (3) Disorganized speech
o (4) Grossly disorganized or catatonic behavior
* (5) Negative symptoms (symptoms that normal person without schizophrenia also has, but just diminished or absent in schizo patients)
o i.e. Affective flattening (no emotion), Avolition (no interest)]

2) Social or occupational dysfunction
* For a significant portion of the time since onset of the disorder, one or more major areas of functioning such as work, interpersonal relations, or self-care are significantly below the level prior to onset.

3) Duration of symptoms ≥ 6 months continuously
* Inclusive of at least 1 month of symptoms fulfilling criterion A (unless successfully treated). This 6 months may include prodromal or residual symptoms.

4) Schizoaffective or mood disorder has been excluded.

5) Disorder is NOT due to a medical disorder or substance use

6) If a history of a pervasive developmental disorder is present, there must be symptoms of hallucinations or delusions present for at least 1 month.

(only 1st five are impt)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 2 most important therapeutic goals for ACUTE stabilisation phase for Schizo?

A
  • Minimize threat to self and others
  • Minimize acute symptoms

Others:
* Improve role functioning
* Identify appropriate psychosocial interventions
* Collaborate with family and caregivers; Support for Carers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the treatment goals for the stabilisation phase? (3)

A
  • Minimize/ prevent relapse -> the more relapses that occur, the more likely that the same treatment used before will not be useful
  • Promote medication adherence
  • Optimize dose and manage adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the most important goal of treatment for maintenance/ stable phase?

A
  • Improve functioning & quality of life

Others:
* Maintain baseline functioning
* Optimize dose vs. Adverse effects
* Monitor for prodromal symptoms of Relapse
* Monitor and manage adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some methods to overcome poor adherence to antipsychotic therapies? (3)

A

1) IM long acting injections

2) Community Psychiatric Nurse -> home visit and administer long acting injection regularly

3) Patient and Family (Caregiver) Education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State the role of Antipsychotics in Schizo, whether treatment is long term/short term and whether relapse will be delayed with cessation (3)

A

o Antipsychotics relieve symptoms of psychosis such as thought disorder, hallucinations and delusions, and prevent relapse

o Long term treatment often necessary

o Relapse often delayed for several weeks after cessation of treatment (due to deposition of lipophilic drug into adipose tissue with chronic use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

State the effects of blocking each of the dopaminergic pathways:

a) Mesolimbic tract
b) Mesocortical tract
c) Nigrostriatal tract
d) Tuberoinfundular tract

A

a) Mesolimbic tract = decrease in positive symptoms of Schizo

b) Mesocortical tract = causes negative symptoms

c) Nigrostriatal tract = causes extrapyrimidal Side Effects

d) Tuberoinfundular tract = causes hyperprolactinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

State the duration of an “adequate” trial of antipsychotic and state which drug is the exception to this duration and that drug’s duration for adequate trial

A

2-6 weeks at optimal therapeutic dose.

Exception is Clozapine and adequate trial of Clozapine is up to 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State when Clozapine is considered to be used in Schizo

A

Consider Clozapine in those who are Treatment Resistant , i.e. those had failed
≥ 2 adequate trials of different antipsychotics (at least 1 should be a SGA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State the DOC for Acute Agitation if Patient is cooperative

A

PO Lorazepam 1-2mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

State what to do for Acute Agitation if Patient is uncooperative

A

Restrain + IM Lorazepam 1-2mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State alternative therapy for Acute Agitation if Patient is cooperative but Benzodiazepine cannot be used (4)

A

PO Risperidone 1-2mg

Also possible:
* Haloperidol* (tab, solution) 2-5mg with pre-treatment ECG (can be difficult to do)
* Quetiapine 50-100mg (tab, immediate release), or
* Olanzapine (tab, orodispersible) 5-10mg, or

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

State alternative therapy for Acute Agitation if Patient is uncooperative but Benzodiazepine cannot be used (4)

A
  • IM Olanzapine (immediate release) 5-10mg; 2nd dose ≥2h after 1st dose; 3rd dose ≥ 4h after 2nd dose.
  • IM Olanzapine and IM Lorazepam must not be given within 1h of each other (risk of cardiorespiratory fatality).
  • IM Aripiprazole (immediate release) 9.75mg: less hypotensive than IM Olanzapine option
  • IM Haloperidol* 2.5-10mg, with pre treatment ECG (but can be difficult to do), or
  • IM Promethazine 25-50mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is DOC for Catatonia

A

PO/IM Benzodiazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the dosing range of PO Haloperidol?

A

5-15mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the maximum daily dose of PO Clozapine?

A

900 mg (450mg BD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is maximum daily dose of PO Quetiapine?

A

800mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is dosing range of PO Risperidone?

A

6mg/day in 1-2 divided doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Name the 3 PO antipsychotics you should NOT use if you want something that is fast acting (Tmax 1-3 hrs)

A

Olanzapine, Aripiprazole, Brexpiprazole

20
Q

Name the antipsychotics that require divided dosing and state what needs to be considered if consolidating dose (2 most impt, 4 others)

A

Chlorpromazine and Clozapine

Risk of hypotension and seizures need to be considered if consolidating doses

Others: Sulpiride; Amisulpride, Quetiapine, Ziprasidone

21
Q

Which 2nd Gen antipsychotics are MOST associated with metabolic side effects (weight GAIN, DM, Hyperlipid)? (2)

A

Clozapine and Olanzapine

22
Q

State the general ADR trend of 1st Gen and 2nd Gen Antipsychotic

A
  • 1st Gen Antipsychotics (Typical or Conventional Antipsychotics) have more extrapyramidal side effects (EPSE) and ↑ Prolactin more compared to 2nd Gen (Atypical Antipsychotics)
  • 2nd Gen Antipsychotics have more metabolic side effects (mainly Clozapine and Olanzapine; those 2 associated with weight gain)
23
Q

Which EPSE is worsened with Anticholinergic use?

A

Tardive dyskinesia

24
Q

State how to manage the various EPSEs

a) Dystonia
b) Pseudo-parkinsonism
c) Akathisia
d) Tardive dyskinesia

A

Dystonia: IM anticholinergics (e.g benztropine 2mg, diphenhydramine)

Pseudo-parkinsons:
- PRN Anticholinergic (1st line)
- Switch to SGA or decrease dose

Akathisia:
- PRN low dose Clonazepam (1st line) and/or Propranolol 20mg TDS
- Switch to SGA or decrease dose

Tardive dyskinesia:
- Discontinue Anticholinergic (worsens TD; 1st line)
- Valbenazine 40-80mg/day (1st line)
- PRN Clonazepam
- Switch to SGA or decrease dose

25
Q

Which SGAs are LEAST associated with metabolic side effects? (4)

A

Aripiprazole, Lurasidone, Brexpiprazole, Ziprasidone

26
Q

State how to manage the metabolic side effects of Antipsychotics (3)

A
  • Treat diabetes (e.g. with metformin), hyperlipidemia
  • Switch to lower risk agents (e.g Aripiprazole, Lurasidone)
  • Lifestyle modification: diet, exercise
27
Q

State how to manage Neuroleptic Malignant Syndrome (NMS) (2)

A
  • IV Dantrolene 50mg TDS (muscle relaxant), oral dopamine agonist (e.g. amantadine, bromocriptine), supportive measures.
  • Switch to SGA
28
Q

State which antipsychotic is most associated with hematological ADRs, and how to manage it

A

Agranulocytosis associated with Clozapine.

Discontinue if severe (WBC <3x10^9/L or ANC<1.5x10^9/L)

29
Q

State how to manage Hyperprolactinemia ADR

A

Switch to Aripiprazole

Alts: Decr dose, use dopamine agonist (Amantadine, bromocriptine)

30
Q

State the general monitoring parameters of antipsychotics and their frequency of monitoring (5)

A

1) BMI (q3 mths when dose stable)

2) HbA1c or Fasting blood sugar (q3 mth after SGA initiation, then annually)

3) Lipids [Low risk patients: q2-5 years; High risk patients: (3 months after initiating SGA), q6 months]

4) EPSE exam (weekly till dose stable, then q3-5mth for FGA, yearly for SGA)

5) Blood pressure (q3 mth after initiation of SGA, then annually)

31
Q

State monitoring parameter specific to Clozapine and the frequency

A

WBC and ANC; weekly for 1st 18 wks then monthly

32
Q

State special considerations when prescribing antipsychotics to elderly (3 impt)

A

1) Avoid drugs with high propensity for alpha 1 adrenergic blockade (orthostatic hypotension) or anticholinergic side effects (constipation, urinary retention, delirium);
2) start low go slow;
3) simplify regime;
4) avoid adverse interactions;
5) avoid long T ½ drugs

33
Q

Which psychiatric drugs have the LEAST CYP interactions? (5)

A

Mirtazapine, Escitalopram, Venlafaxine, Desvenlafaxine, Vortioxetine

34
Q

State the clinically significant DDIs for Antipsychotics in general, and those for Clozapine. (4,3)

A

1) CNS depressant

2) alpha-1 adrenergic blocker, dopamine blocker (e.g metoclopramide), antihistamine, antimuscarinic

3) antihypertensive (inc hypotension)

4) dopamine agonists (antagonistic effect)

5) CBZ and other drugs that cause agranulocytosis

6) CYP1A2 inhibitor/inducer

35
Q

State examples of CYP1A2 inhibitors (3)

A

Macrolide, Fluvoxamine, FQs

36
Q

State the time course of treatment response (early vs late improvements) and the clinical effects seen

A

Early
1 wk: decr agitation
2-4 wk: decr hallucination and paranoia

Late:
6-12wk: decr delusion
3-6mths: improve cognition

37
Q

State the psychiatric drugs that are potent CYP2D6 inhibitors (3)

A

Buproprion, Fluoxetine, Paroxetine

38
Q

Which CYP enzymes do Fluvoxamine inhibit?

A

CYP1A2, 2C19

39
Q

State the MOA at which SGAs may help improve negative symptoms

A

5HT-2A antagonism

40
Q

State examples of CYP1A2 inducers (4).

A
  • Rifampicin
  • Phenobarbital
  • Phenytoin
  • Cigarette smoke
41
Q

State the symptoms of NMS (5)

A
  • Muscle rigidity (lead pipe)
  • High fever,
  • Autonomic dysfunction (inc PR, labile BP, diaphoresis)
  • Altered consciousness (confused etc)
  • Inc CK (rhabdomyolysis)
42
Q

Which antipsychotics are associated with the least side effects (e.g tremor, muscle stiffness, weight gain, DM)?

A

Aripiprazole and Brexpiprazole

43
Q

Which FGA associated with the most weight gain?

A

Chlorpromazine (Perphenazine also)

44
Q

Which Antipsychotic has best evidence in reducing suicidality in patients?

A

Clozapine

45
Q

Which SGA has the most anticholinergic effect?

A

Clozapine

46
Q

Dosing range of Olanzapine?

A

5-20mg/day

47
Q

What is the most important counselling point regarding Clozapine ADR?

A

If get fever, cough, sore throat, go see doctor immediately